Amathus Therapeutics

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://amathustx.com

Last Round

Corporate Funding

Mar 17, 2021

Company Overview

Amathus Therapeutics is a biotechnology company that develops small-molecule therapeutics targeting organelle-specific chaperones for the treatment of neurodegenerative and renal diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small-molecule therapeuticsdrug discoverybiotechneurodegenerative diseasebiopharmamitochondrial dysfunctionrenal diseasechaperone modulatorsearly-stage biotechpreclinical researchtherapeutic pipelinedrug developmentpharma partnershipTRAP1 modulatorsdrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amathus Therapeutics Comparables

Compare Amathus Therapeutics with similar companies based on industry and business-model similarity.

Amathus Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Vincere Biosciences	89%
MitoRx Therapeutics	81%
Pretzel Therapeutics	80%

View all Comparables

Amathus Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Corporate Funding	Mar 17, 2021

View all Funding Rounds

Amathus Therapeutics Investors

Notable investors and investment history

Amathus Therapeutics investors
Investor	Rounds
Sanofi Ventures	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 17, 2021
Merck & Co., Inc. led the corporate funding round.

View all signals

Amathus Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Amathus Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amathus Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range1

Year Founded2016

Last FundingMar 17, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?